Marline G. Harmsen

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Menopause-related quality of life five years after salpingectomy with delayed oophorectomy versus Salpingo-Oophorectomy.

Menopause-related quality of life five years after salpingectomy with delayed oophorectomy versus Salpingo-Oophorectomy.

Journal: Journal of the National Cancer Institute

Published: December 15, 2025

Menopause-related quality of life 5 years after salpingectomy with delayed oophorectomy vs salpingo-oophorectomy.

Menopause-related quality of life 5 years after salpingectomy with delayed oophorectomy vs salpingo-oophorectomy.

Journal: Journal of the National Cancer Institute

Published: December 15, 2025

Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study.

Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study.

Journal: Maturitas

Published: August 12, 2025

Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference Trial.

Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference Trial.

Journal: BJOG : an international journal of obstetrics and gynaecology

Published: July 01, 2024

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis.

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis.

Journal: Human reproduction update

Published: May 23, 2022

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors.

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: August 18, 2021

Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.

Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.

Journal: JAMA oncology

Published: June 03, 2021

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.

Journal: Gynecologic oncology

Published: May 10, 2021

Further insights into the role of tumour characteristics in survival of young women with epithelial ovarian cancer.

Further insights into the role of tumour characteristics in survival of young women with epithelial ovarian cancer.

Journal: Gynecologic oncology

Published: January 03, 2019

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.

Journal: Health expectations : an international journal of public participation in health care and health policy

Published: December 01, 2017

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

Journal: Cancer

Published: September 29, 2017

Opportunistic salpingectomy in women undergoing hysterectomy: Results from the HYSTUB randomised controlled trial.

Opportunistic salpingectomy in women undergoing hysterectomy: Results from the HYSTUB randomised controlled trial.

Journal: Maturitas

Published: August 11, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026